Research & Development



  阿嬌扭動著動人的身體依偎進劉徹懷里道︰“妾以為您要的太多了。”   曹襄瞅著碗里的羊寶貝,嘆了口氣,就大口的喝湯吃肉,一碗大補湯下肚,渾身暖和。超碰资源视频总站   與他們這種超級勛貴爭斗毫無意義,戰勝了,會把長平公主,阿嬌貴人這樣的人引出來,戰敗了,就會被他們連皮帶骨吃的干干淨淨。牛牛视频超碰在线福利   胡姬能听懂曹襄的話,很體貼的給他端來了一碗滾燙的羊湯。   有了這座重鎮,即便是陽關,玉門,敦煌,酒泉,張掖這些地方全失,還有獨石城可以抵擋來自荒原沙漠的強敵。超碰在线观看   學了衛青的軍國之道,劉據就能統御衛青昔日的袍澤。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo